Churbz, our JV jet setting CEO does understand. It is just that the stock price at this juncture is something that is 2ndary to getting all the ducks lined up. And that is taking more time than he originally thought, imo. He knows he needs to execute and knows that the stock price will follow once he can execute. His biggest problem, one that we all know, is that he telegraphed things that never materialized and most importantly screwed up the Lympro data back in July. Hopefully, all will be corrected once he can show that Amarantus' portfolio of diagnostics and therapies is what BP wants and needs and that he can get what he wants for them either through an out right purchas of them or licensing.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.